Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin vs Estrogen vs Placebo for Postmenopausal Hot Flashes
NCT00276081Phase 4Completed
- Sponsor
- University of Rochester
- Start
- May 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of gabapentin in hot flashes (3 arms), sponsored by University of Rochester. Primary endpoint: Reduction in hot flash frequency. Started May 2002; status: completed.
02
Drugs
gabapentin
03
Conditions
hot flashes
Beyond the preview
Go deeper on NCT00276081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00276081.